| Augmenting adaptive immunity: progress and challenges in the quantitative engineering and analysis of adaptive immune receptor repertoires AJ Brown, I Snapkov, R Akbar, M Pavlović, E Miho, GK Sandve, V Greiff Molecular Systems Design & Engineering 4 (4), 701-736, 2019 | 37 | 2019 |
| The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis I Snapkov, CO Öqvist, Y Figenschau, P Kogner, JI Johnsen, ... BMC cancer 16 (1), 1-12, 2016 | 34 | 2016 |
| A compact vocabulary of paratope-epitope interactions enables predictability of antibody-antigen binding R Akbar, PA Robert, M Pavlović, JR Jeliazkov, I Snapkov, A Slabodkin, ... Cell Reports 34 (11), 108856, 2021 | 26 | 2021 |
| Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability in vitro and impairs tumor growth in vivo C Tümmler, I Snapkov, M Wickström, U Moens, L Ljungblad, LHM Elfman, ... Oncotarget 8 (56), 95135, 2017 | 25 | 2017 |
| Agnoprotein of polyomavirus BK interacts with proliferating cell nuclear antigen and inhibits DNA replication N Gerits, M Johannessen, C Tümmler, M Walquist, S Kostenko, I Snapkov, ... Virology journal 12 (1), 1-14, 2015 | 25 | 2015 |
| immuneSIM: tunable multi-feature simulation of B-and T-cell receptor repertoires for immunoinformatics benchmarking CR Weber, R Akbar, A Yermanos, M Pavlović, I Snapkov, GK Sandve, ... Bioinformatics 36 (11), 3594-3596, 2020 | 19 | 2020 |
| Each pregnancy linearly changes immune gene expression in the blood of healthy women compared with breast cancer patients E Lund, A Nakamura, I Snapkov, JC Thalabard, KS Olsen, L Holden, ... Clinical epidemiology 10, 931, 2018 | 10 | 2018 |
| FITC conjugation markedly enhances hepatic clearance of N-formyl peptides CI Øie, I Snapkov, K Elvevold, B Sveinbjørnsson, B Smedsrød Plos one 11 (8), e0160602, 2016 | 5 | 2016 |
| The future of blood testing is the immunome RA Arnaout, ETL Prak, N Schwab, F Rubelt Frontiers in immunology 12, 2021 | 4 | 2021 |
| immuneML: an ecosystem for machine learning analysis of adaptive immune receptor repertoires M Pavlovic, L Scheffer, K Motwani, C Kanduri, R Kompova, N Vazov, ... bioRxiv, 2021 | 3 | 2021 |
| In silico proof of principle of machine learning-based antibody design at unconstrained scale R Akbar, PA Robert, CR Weber, M Widrich, R Frank, M Pavlović, ... BioRXiV, 2021 | 2 | 2021 |
| A finite vocabulary of antibody-antigen interaction enables predictability of paratope-epitope binding R Akbar, JR Jeliazkov, PA Robert, I Snapkov, M Pavlović, A Slabodkin, ... bioRxiv, 759498, 2019 | 2 | 2019 |
| One billion synthetic 3D-antibody-antigen complexes enable unconstrained machine-learning formalized investigation of antibody specificity prediction PA Robert, R Akbar, R Frank, M Pavlović, M Widrich, I Snapkov, ... BioRXiV, 2021 | 1 | 2021 |
| Individualized VDJ recombination predisposes the available Ig sequence space A Slabodkin, M Chernigovskaya, I Mikocziova, R Akbar, L Scheffer, ... bioRxiv, 2021 | 1 | 2021 |
| Breast cancer women lack normal immune response after full-term pregnancies. E Lund, A Nakamura, I Snapkov, JC Thalabard, KS Olsen, L Holden, ... Norsk Epidemiologi 28, 2018 | 1 | 2018 |
| The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis I Snapkov, CO Öqvist, YA Figenschau, P Kogner, JI Johnsen, ... Cancer Research 75 (15 Supplement), 3283-3283, 2015 | 1 | 2015 |
| Expression of chemerin and chemerin receptors in neuroblastoma: implications in tumorigenesis C Tuemmler, I Snapkov, UL Moens, P Kogner, JI Johnsen, ... Cancer Research 75 (15 Supplement), 3279-3279, 2015 | 1 | 2015 |
| Progress and challenges in mass spectrometry-based analysis of antibody repertoires I Snapkov, M Chernigovskaya, P Sinitcyn, K Lê Quý, TA Nyman, V Greiff Trends in Biotechnology, 2021 | | 2021 |
| The blood transcriptome prior to ovarian cancer diagnosis: A case-control study in the NOWAC postgenome cohort M Jareid, I Snapkov, M Holden, LTR Busund, E Lund, TH Nøst Plos one 16 (8), e0256442, 2021 | | 2021 |
| Dynamic changes in the T cell receptor repertoire during treatment with radiotherapy combined with an immune checkpoint inhibitor ÅK Öjlert, D Nebdal, I Snapkov, V Olsen, J Kidman, V Greiff, J Chee, ... Molecular Oncology, 2021 | | 2021 |
